Abstract

Near infrared photoimmunotherapy (NIR-PIT) is a newly developed cancer therapy that relies on the binding of a near-infrared antibody photoabsorber conjugate (APC) to a cancer cell. Subsequent exposure to NIR light selectively induces rapid necrotic cell death on target-expressing cells with minimal off-target effects. When treated with NIR-PIT, targeted cells become swollen, develop blebs and burst within minutes of light exposure. Detailed spatial and temporal morphological changes of the cellular membrane of targeted cells treated with NIR-PIT have not been fully explored with state-of-the-art microscopic methods. In this study, we investigated the morphologic and kinetic effects of PIT on two types of cells, a spindle-shaped 3T3/Her cell and a spheric-shaped MDA-MB468 cell, after NIR-PIT using three-dimensional low-coherent quantitative phase microscopy (3D LC-QPM). Adhesive cells treated with NIR-PIT demonstrated region-specific cell membrane rupture occurring first on the distal free edge of the cell near the site of adhesion, in a process that was independent of cell shape. The results show that the peripheral portions of the cell membrane near the site of adhesion are particularly vulnerable to the effects of NIR-PIT, likely because these sites exhibit higher baseline surface tension.

Highlights

  • Near infrared photoimmunotherapy (NIR-PIT) is a newly developed cancer therapy in which a monoclonal antibody is conjugated to a near-infrared photoabsorber, IRDye700DX (IR700), which is a silica-phthalocyanine derivative [1]

  • Near infrared photoimmunotherapy (NIR-PIT) is a newly developed cancer therapy that relies on the binding of a near-infrared antibody photoabsorber conjugate (APC) to a cancer cell

  • The dynamic 3D threedimensional dynamic low-coherent quantitative phase microscopy (LC-QPM) imaging showed that 3T3/Her cells and MDA-MB468 cells increased in volume and changed in shape following NIR light exposure (Figures 1 and 2)

Read more

Summary

Introduction

Near infrared photoimmunotherapy (NIR-PIT) is a newly developed cancer therapy in which a monoclonal antibody is conjugated to a near-infrared photoabsorber, IRDye700DX (IR700), which is a silica-phthalocyanine derivative [1]. After the antibody-photoabsorber conjugate (APC) is administered and binds to the cancer cell membrane expressing the cognate antigen, NIR light activates the APC resulting in highly selective cell death of the cancer cells with minimal effects on surrounding normal cells. Within minutes of NIR light exposure, the targeted cells become swollen, bleb and rupture [2, 3]. The process of cancer cell death following NIR-PIT occurs within several minutes of NIR exposure. NIR-PIT is a novel therapy that rapidly and efficiently induces immunogenic cell death (ICD) via cellular necrosis

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call